Status:
COMPLETED
A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion
Lead Sponsor:
University of Michigan Rogel Cancer Center
Conditions:
Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Researchers at the the University of Michigan are conducting a research project to assess how a course of radiation therapy changes the way blood flows through the liver. To be able to do this, the re...
Eligibility Criteria
Inclusion
- Patients must be ≥18 years of age.
- The patient's planned cancer management is radiation to the liver with or without chemotherapy.
- Patients must have a performance status of 0-2 and a life expectancy of at least 3 months.
- Patients should have no contraindications to having a contrast enhanced MRI scan.
Exclusion
- Women who are pregnant or breastfeeding are excluded.
- Prisoners are excluded
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT01210027
Start Date
March 1 2007
End Date
April 1 2023
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States, 48109